Document is current
Any future updates will be listed below
-
Authors
Sbaihat, Hasan
Roenneke, Katharina
Müller, Dajana
Ladopoulos, Theodoros
Schneider, Ruth
Krieger, Britta
Bellenberg, Barbara
Lukas, Carsten https://orcid.org/0000-0002-8562-9697
-
Funding
Funding for this research was provided by:
Ruhr-Universität Bochum
- License Information
-
More Information
Article History
Received: 23 May 2025
Revised: 29 July 2025
Accepted: 3 August 2025
First Online: 15 August 2025
Declarations
:
: Hasan Sbaihat, Anna Katharina Roenneke, Dajana Müller, Britta Krieger, and Barbara Bellenberg have no disclosures/conflicts of interest to declare. Theodoros Ladopoulos has received research scientific grant support from Novartis Pharma; Ruth Schneider has received speaker’s honoraria from Biogen Idec GmbH, Alexion Pharma, Novartis Pharma and Roche Pharma AG, congress travel support from Merck, Biogen Idec GmbH and has received research scientific grant support from Novartis Pharma; Carsten Lukas has received consulting and speaker’s honoraria from Biogen Idec, Bristol Myers Squibb, Bayer HealthCare, Daiichi Sanykyo, Merck Serono, Novartis and Sanofi.
